Ascertainment of Small Airways Dysfunction Using Oscillometry to Better Define Asthma Control and Future Risk: Are We Ready to Implement It in Clinical Practice?
- PMID: 39734054
- PMCID: PMC12106962
- DOI: 10.1016/j.chest.2024.12.020
Ascertainment of Small Airways Dysfunction Using Oscillometry to Better Define Asthma Control and Future Risk: Are We Ready to Implement It in Clinical Practice?
Abstract
The small airways comprise generations 8 to 23 of the bronchial tree, consist of airways with an internal diameter < 2 mm, and are classically difficult to assess and treat in persistent asthma. Small airways dysfunction (SAD) is integral to the asthma management paradigm because it is associated with poorer symptom control and greater levels of type 2 inflammation, and it has been proposed as a potentially treatable asthma trait. Although identification of SAD based on oscillometry has been found to be clinically useful in managing asthma, very few physicians, including specialists, use this technique as part of standard or adjunct evaluation of lung function to diagnose asthma, grade severity of airway obstruction, ascertain disease control or the risk for future exacerbations, or to make management decisions. To rectify the unrecognized value of oscillometry in the asthma community, a consortium of authors who are investigators with knowledge and experience of oscillometry wished to address the most important clinical questions raised by our colleagues who are considering using this technique, including its clinical utility. In this article, we discuss integral concepts, including applicability of oscillometry as a predictive tool for asthma exacerbations and disease control, adequacy of spirometry and oscillometry in assessing SAD, potential limitations of oscillometry, and treatment options for SAD.
Keywords: asthma; oscillometry; small airways dysfunction.
Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Financial/Nonfinancial Disclosures The authors have reported to CHEST the following: R. C. reports institutional grants from Chiesi; advisory boards for AstraZeneca; personal fees (talks) from AstraZeneca, Chiesi, and Thorasys; support for attending meetings from AstraZeneca, Chiesi, NIOX, and Sanofi-Regeneron; and honoraria (drafting educational material) from AstraZeneca and Vitalograph. L. G.-R. reports personal fees for conferences from GlaxoSmithKline, Chiesi, and Thorasys; and support for attending European Respiratory Society Congress from Chiesi. E. A. G. has received institutional grants from Gilead, Circassia, Chiesi, Propeller Health, Helicon Health, Adherium Ltd, and AstraZeneca; and personal fees from Circassia and Sanofi. F. M. D. has received unrestricted research funds from AstraZeneca, Covis Pharma, GlaxoSmithKline, Merck Canada, Novartis, Teva, Trudell Medical, GlaxoSmithKline, and MEDTEQ in partnership with Thorasys Inc; honoraria for consultancy work from AstraZeneca, Covis Pharma, Sanofi, Teva, and Thorasys Inc; and honoraria as an invited speaker from Covis Pharma, Jean-Coutu Pharmacy, and Brunet Pharmacy. None declared (M. C., P. C., S. P. G.).
Figures




Similar articles
-
Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study.Lancet Respir Med. 2019 May;7(5):402-416. doi: 10.1016/S2213-2600(19)30049-9. Epub 2019 Mar 12. Lancet Respir Med. 2019. PMID: 30876830
-
Oscillometry in severe asthma: the state of the art and future perspectives.Expert Rev Respir Med. 2023 Jul-Dec;17(7):563-575. doi: 10.1080/17476348.2023.2237872. Epub 2023 Jul 20. Expert Rev Respir Med. 2023. PMID: 37452692 Review.
-
Small airway dysfunction measured by impulse oscillometry is associated with exacerbations and poor symptom control in patients with asthma treated in a tertiary hospital subspecialist airways disease clinic.Front Allergy. 2024 Aug 15;5:1403894. doi: 10.3389/falgy.2024.1403894. eCollection 2024. Front Allergy. 2024. PMID: 39210978 Free PMC article.
-
Oscillometry-defined small airways dysfunction as a treatable trait in asthma.Ann Allergy Asthma Immunol. 2025 Feb;134(2):151-158. doi: 10.1016/j.anai.2024.11.006. Epub 2024 Nov 15. Ann Allergy Asthma Immunol. 2025. PMID: 39549987 Review.
-
Adding Oscillometry and Fractional Exhaled Nitric Oxide to Guidelines Potentially Enhances Identification of Exacerbation Risk Factors in Asthmatic Children.Pediatr Pulmonol. 2025 Jan;60(1):e27379. doi: 10.1002/ppul.27379. Epub 2024 Dec 2. Pediatr Pulmonol. 2025. PMID: 39620380
Cited by
-
Changes in Small Airway Physiology Measured by Impulse Oscillometry in Subjects with Allergic Asthma Following Methacholine and Inhaled Allergen Challenge.J Clin Med. 2025 Jan 30;14(3):906. doi: 10.3390/jcm14030906. J Clin Med. 2025. PMID: 39941577 Free PMC article.
References
-
- Bateman E.D., Boushey H.A., Bousquet J., et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med. 2004;170(8):836–844. - PubMed
-
- Cottini M., Licini A., Lombardi C., Berti A. Prevalence and features of IOS-defined small airway disease across asthma severities. Respir Med. 2021;176 - PubMed
-
- Kuo C.R., Jabbal S., Lipworth B. Is small airways dysfunction related to asthma control and type 2 inflammation? Ann Allergy Asthma Immunol. 2018;121(5):631–632. - PubMed
-
- Cottini M., Lombardi C., Comberiati P., et al. Oscillometry defined small airways dysfunction as a treatable trait in asthma. Ann Allergy Asthma Immunol. 2025;134(2):151–158. - PubMed
-
- Cottini M., Bondi B., Bagnasco D., et al. Impulse oscillometry defined small airway dysfunction in asthmatic patients with normal spirometry: prevalence, clinical associations, and impact on asthma control. Respir Med. 2023;218 - PubMed